Researcher
Raffaella Ravinetto
- Keywords:research ethics, quality of medicines, access to medicines, B740-pharmacy, equity, pharmaceutical policies
Affiliations
- Pharmaceutical Public Health (Research unit)
Member
From1 Jul 2023 → Today - Pharmaceutical Public Health (Research unit)
Member
From1 Nov 2006 → Today - Equity and Health (Research unit)
Member
From1 Nov 2006 → 5 Sep 2023 - Equity and Health (Research unit)
Member
From1 Nov 2006 → 22 Aug 2023 - Clinical Trials Unit (Research unit)
Member
From31 Oct 2006 → 9 Nov 2016 - Clinical Trials Unit (Research unit)
Member
From31 Oct 2006 → 16 Apr 2015
Projects
1 - 6 of 6
- Non-commercial clinical research in neglected tropical diseasesFrom11 Jul 2018 → 31 Dec 2020
- A Directed Search for a Treponema pallidum Antigen TestFrom1 Jul 2013 → 28 Feb 2019
- Care package for treatment and control of visceral leishmaniasis in East AfricaFrom1 Jan 2013 → 31 Dec 2016
- Methodological and ethical challenges in sponsorship of non-commercial North-South collaborative researchFrom14 Jan 2012 → 27 Jan 2016
- Towards strenghtening of the West African Node of excellence for TB, AIDS & MalariaFrom27 Oct 2011 → 31 Aug 2014
- Impact of the clinical trials on the health behaviours of the communities and the quality of the health services in West and East AfricaFrom6 Jun 2011 → 6 Jun 2013
Publications
1 - 10 of 122
- Shaping the future of global access to safe, effective, appropriate and quality health products(2024)
Authors: Raffaella Ravinetto, Aquiles Rodrigo Henriquez-Trujillo, Prashant N Srinivas, Hazel Bradley, Renier Coetzee, Theresa J Ochoa, Jean Claude Semuto Ngabonziza, Jean-Baptiste Mazarati, W Van Damme, Remco van de Pas, et al.
- Evaluation of rational medicines use based on World Health Organization core indicators: a cross-sectional study in five health districts in Mauritania(2024)
Authors: Mohamed Ali Ag Ahmed, Raffaella Ravinetto, Khadijetou Diop, Verónica Trasancos Buitrago, Catherine Dujardin
Pages: 17-29 - International guidelines on good governance practice for research institutions(2023)
Authors: Raffaella Ravinetto, Dirk Lanzerath, Roli Mathur, Kotone Matsuyama, Winfred Nazziwa, Francine Ntoumi, Lembit Rägo, Andreas A Reis, Vladislava Talanova, Creany Wong, et al.
Number of pages: 70 - Researchers’ responsibilities in resource-constrained settings: experiences of implementing an ancillary care policy in a vaccine trial in the Democratic Republic of the Congo.(2023)
Authors: Gwen Lemey, Trésor Zola, Ynke Larivière, Solange Milolo, Engbu Danoff, lazarre bakonga, Emmanuel Esanga Longomo, Peter Vermeiren, Vivi Maketa, Junior Matangila, et al.
- Access to medicines for NCD prevention and control(2023)
Authors: Cécile Macé, David Beran, Raffaella Ravinetto, Christophe Perrin
Pages: 326-331Number of pages: 6 - Globalisation of industry-sponsored clinical trials for breast, lung and colon cancer research: trends, threats and opportunities.(2023)
Authors: A. B. Payedimarri, Mouhssin Samir, Saleh Aljadeeah, Gianluca Gaidano, Raffaella Ravinetto
- Responsible dissemination of health and medical research: some guidance points(2023)
Authors: Raffaella Ravinetto, Jerome Amir Singh
Pages: 144-147 - Global Evidence on Assuring Quality of Medicines(2023)
Authors: Huma Rasheed, Rabia Khokhar, Raffaella Ravinetto, Zaheer-Ud-Din Babar
Pages: 1-15Number of pages: 15 - Challenges of antibiotic formulations and administration in the treatment of bloodstream infections in children under five admitted to Kisantu Hospital, Democratic Republic of Congo(2023)
Authors: Bieke Tack, Daniel Vita, Emmanuel Ntangu, Japhet Ngina, Pathy Mukoko, Adèle Lutumba, Dina Vangeluwe, Jaan Toelen, Karel Allegaert, Octavie Lunguya, et al.
Pages: 1245-1259 - Usefulness of medicine screening tools in the frame of pharmaceutical post-marketing surveillance(2023)
Authors: Christelle Ange Waffo Tchounga, Pierre-Yves Sacré, Raffaella Ravinetto, Marya Lieberman, Patient Hamuli Ciza, Rose Ngono Mballa, Eric Ziemons, Philippe Hubert, Roland Djang'eing'a Marini